- In March 2021, Johnson & Johnson (US) launched the ECHELON+ Stapler, a powered surgical stapler designed to reduce complications in surgery through more uniform tissue compression and better staple formation.
Northbrook, IL 60062 -- (SBWIRE) -- 09/07/2022 -- Anastomosis Device Market is projected to grow from USD 3.0 billion in 2022 to USD 4.4 billion by 2027, at a CAGR of 8.3% from 2022 to 2027 according to a new report by MarketsandMarkets™. The increasing incidence of target diseases and the subsequent growth in the number of surgical procedures, the growing demand for minimally invasive surgeries, and technological advancements are the major factors driving the market's growth. Emerging economies such as China, Japan, and India are providing profitable opportunities for the players operating in the market.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=5343963
Browse in-depth TOC on "Anastomosis Device Market"
289 – Tables
42 – Figures
305 – Pages
"Surgical Staplers segment accounted for the largest share of the anastomosis devices market, by product."
The anastomosis device market is segmented into surgical staplers, surgical sutures, and surgical sealants & adhesives. In 2021, the surgical staplers segment accounted for the largest share of the market. The surgical staplers market is further segmented into manual and powered surgical staplers. In 2021, the manual surgical staplers segment accounted for the largest share of the surgical staplers market. The large share of this segment can be attributed to the wide range of advantages associated with these devices, such as ease of use, minimal risk of complications like blood loss/leakage, shorter operating time, and reduced hospital costs.
"Cardiovascular & Thoracic Surgery accounted for the largest share in the market, by application."
The anastomosis device market has been segmented into cardiovascular & thoracic surgery, gastrointestinal surgery, orthopaedic surgery, gynaecological surgery, and other applications. In 2021, the cardiovascular & thoracic surgery segment accounted for the largest share of the temperature monitoring market. Market growth can largely be attributed to the many cardiovascular surgeries performed across the globe because of the high incidence of cardiovascular disease (CVD), the increasing number of coronary and percutaneous cardiology interventions, and the growing adoption of anastomosis devices in these surgical procedures.
"Hospitals segment accounted for the largest share in the market, by end users."
The anastomosis device market has been segmented into hospitals, ambulatory surgery centers, and other end users. In 2021, hospitals are estimated to be the largest end users of the market. The large share of this segment can be attributed to the increasing number of complex surgeries performed in hospitals, the growing geriatric population, favourable reimbursement policies for hospital treatments, and the growing number of new hospitals, especially in emerging countries.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=5343963
"North America is the largest regional market for anastomosis devices."
The global anastomosis device market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2021, North America accounted for the largest share of the market. The large share of North America in the global market can be attributed to the positive reimbursement scenario in the US, the rising incidence of cancer, and the implementation of a new funding model for Canadian hospitals.
The key players in anastomosis device market are Johnson & Johnson (US), Medtronic Plc (Ireland), B. Braun Melsungen (Germany), Intuitive Surgical Inc. (US), Boston Scientific Corporation (US), Artivion, Inc. (US), Smith & Nephew Plc (UK), Becton, Dickinson and Company (US), CONMED Corporation (US), Advanced Medical Solutions Group Plc (UK), Baxter International, Inc. (US), Teleflex (US), Meril Life Sciences (India), Surgical Specialties Corporation (US), Péters Surgical (France), DemeTECH Corporation (US), Purple Surgical (UK), Internacional Farmacéutica S.A. de C.V. (Mexico), BioSintex (Romania), Lotus Surgicals (India), Mellon Medical (Netherlands), and Frankenman International (China), EndoEvolution (US), Welfare Medical (UK) and Unisur Lifecare (India).
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=5343963